In re Sugammadex Bridion® (Sugammadex Sodium)

Case Name: In re Sugammadex, No. 20-CV-2576 (CCC/LDW), 2023 WL 3966146 (D.N.J. June 13, 2023) (Cecchi, J.) Drug Product and Patent(s)-in-Suit: Bridion® (sugammadex sodium); U.S. Patent No. RE44,733 (“the ’733 patent”)….
By: Robins Kaplan LLP
Previous Story

DHS Announces New Artificial Intelligence and Facial Recognition, Face Capture, and Facial Analysis Policies

Next Story

Lawmakers Raise Concerns Over Worker Safety at Amazon Warehouses